0.01%阿托品作为近视控制疗法是否有一席之地？

{"title":"0.01%阿托品作为近视控制疗法是否有一席之地？","authors":"Jason C Yam, Safal Khanal, John R Phillips","doi":"10.1111/opo.13490","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":19522,"journal":{"name":"Ophthalmic and Physiological Optics","volume":" ","pages":"929-935"},"PeriodicalIF":2.8000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12087867/pdf/","citationCount":"0","resultStr":"{\"title\":\"Does 0.01% atropine have a place as a myopia control therapy?\",\"authors\":\"Jason C Yam, Safal Khanal, John R Phillips\",\"doi\":\"10.1111/opo.13490\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":19522,\"journal\":{\"name\":\"Ophthalmic and Physiological Optics\",\"volume\":\" \",\"pages\":\"929-935\"},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2025-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12087867/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Ophthalmic and Physiological Optics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/opo.13490\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/4/7 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"OPHTHALMOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ophthalmic and Physiological Optics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/opo.13490","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/7 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}